Trials / Completed
CompletedNCT00475397
Duloxetine Stress Urinary Incontinence Efficacy and Safety Study
Efficacy and Safety of Duloxetine Compared With Placebo in Subjects With Stress Urinary Incontinence
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 120 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- Female
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
Study F1J-MC-SBBU will examine the effect of duloxetine treatment in women with SUI. The inclusion and exclusion criteria of this Phase 3 study will ensure that all subjects have a clinical diagnosis of SUI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | |
| DRUG | Placebo |
Timeline
- Start date
- 2003-12-01
- Completion
- 2004-10-01
- First posted
- 2007-05-21
- Last updated
- 2007-05-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00475397. Inclusion in this directory is not an endorsement.